Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 15Endometrial Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Squamous Cell Carcinoma of Head and Neck 5Neoplasm Metastasis 5Breast Neoplasms 5Uterine Cervical Neoplasms 4Rectal Neoplasms 4Ovarian Neoplasms 4Head and Neck Neoplasms 4Pancreatic Neoplasms 3Melanoma 3Colonic Neoplasms 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Osteosarcoma 2Locally Advanced Rectal Cancer (LARC) 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Neuroendocrine 2Carcinoma, Hepatocellular 2Carcinoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1

Interventions

dostarlimab 2sintilimab 1XELOX 1Radiotherapy 1Oxaliplatin 1Neoadjuvant Therapy 1Immune Checkpoint Inhibitors 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Locally Advanced Rectal Cancer (LARC) × dostarlimab × 1 year × Clear all
NCT07381777 2026-02-02

IMMUNOSTAR

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 2 Not yet recruiting
270 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

NCT07269249 2025-12-08

RW-NEDOS

National Cancer Institute, Naples

Recruiting
50 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡